Company intelligence / Profile preview

Brain Trust Accelerator Fund

Burlingame, California, United States

Ownership: Private
Development stage: Other

Overview

Brain Trust Accelerator Fund II is an active venture capital fund that focuses on translational stage investments in brain-related diseases, targeting the diagnosis and treatment of neurological conditions. It is not a drug/biotech operator but rather a life science investment fund with a track record of catalyzing clinical programs via its portfolio companies.

Industry: Investors

Beyond the preview

Go deeper on Brain Trust Accelerator Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain Trust Accelerator Fund.

Explore the full profile